SCHEMBL4265268

SCHEMBL4265268

O=C(O)C(Cc1cccc(F)c1)NS(=O)(=O)C1(c2c(Cc3ccccc3)oc3ccccc23)C=CC(c2ccccc2)=CC1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 5/20 0.39
ADAMTS4 O75173 2/20 0.39
MMP13 P45452 1/20 0.39
MMP14 P50281 1/20 0.39
PTPN1 P18031 8/20 0.37
PTPRF P10586 1/20 0.35
PTPRA P18433 1/20 0.35
PTPN7 P35236 1/20 0.35
DUSP3 P51452 1/20 0.35
MTNR1A P48039 2/20 0.34
MTNR1B P49286 2/20 0.34
MMP9 P14780 3/20 0.34
ALB P02768 1/20 0.33
IL2 P60568 1/20 0.33
TP53 P04637 1/20 0.33
MME P08473 1/20 0.33
ECE1 P42892 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4275242 0.94 MMP2 (0.40) MMP2ADAMTS4MMP13MMP14PTPN1
SCHEMBL4267918 0.84 PTPN1 (0.36) MMP2ADAMTS4MMP13MMP14PTPN1
SCHEMBL4261640 0.84 PTPN1 (0.38) MMP2ADAMTS4MMP13MMP14PTPN1
SCHEMBL5743849 0.80 TAS2R14 (0.35) PTPN1DUSP3MTNR1AMTNR1B
SCHEMBL4264638 0.79 MMP2 (0.42) MMP2ADAMTS4MMP13MMP14PTPN1
SCHEMBL4260729 0.78 PTPN1 (0.35) MMP2ADAMTS4MMP13MMP14PTPN1
SCHEMBL4267881 0.77 PTPN1 (0.34) MMP2ADAMTS4MMP13MMP14PTPN1
SCHEMBL4273027 0.73 MMP2 (0.56) MMP2ADAMTS4MMP13MMP14PTPN1
SCHEMBL4273033 0.73 MMP2 (0.56) MMP2ADAMTS4MMP13MMP14PTPN1
SCHEMBL4267916 0.72 ECE1 (0.37) MMP2ADAMTS4MMP13MMP14PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090082392-A1 Substituted Carboxylic Acids THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY LLC 2009-03-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090082392-A1 Substituted Carboxylic Acids PTPRJ, PTPRS, PTPRG MMP2 3614/4885ADAMTS4 4500/4885MMP13 4095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.